Loss-of-function variants in the KCNQ5 gene are implicated in genetic generalized epilepsies-Reference-Cited by-同舟云学术

Loss-of-function variants in the KCNQ5 gene are implicated in genetic generalized epilepsies

Published:2022-10 Issue: Volume:84 Page:104244
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Krüger Johanna,Schubert Julian,Kegele Josua,Labalme Audrey,Mao Miaomiao,Heighway Jacqueline,Seebohm Guiscard,Yan Pu,Koko Mahmoud,Aslan-Kara Kezban,Caglayan Hande,Steinhoff Bernhard J.,Weber Yvonne G.,Keo-Kosal Pascale,Berkovic Samuel F.^ORCID,Hildebrand Michael S.,Petrou Steven,Krause Roland,May Patrick^ORCID,Lesca Gaetan,Maljevic Snezana,Lerche Holger

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference39 articles.

1. Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity;Lerche;J Biol Chem,2000

2. KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents;Schroeder;J Biol Chem,2000

3. KCNQ2 and KCNQ3 potassium channel subunits: Molecular correlates of the M-channel;Wang;Science,1998

4. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias;Wang;Nat Genet,1996

5. A potassium channel mutation in neonatal human epilepsy;Biervert;Science,1998

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retigabine and gabapentin restore channel function and neuronal firing in a cellular model of an epilepsy-associated dominant-negative KCNQ5 variant;Neuropharmacology;2024-06

2. Potential therapeutic targets for hypotension in duchenne muscular dystrophy;Medical Hypotheses;2024-04

3. The Role of Ion Channel in Epilepsy Including SUDEP Cases;Handbook of Neurodegenerative Disorders;2024

4. The Role of Ion Channel in Epilepsy Including SUDEP Cases;Handbook of Neurodegenerative Disorders;2024

5. Therapeutic Targeting of Potassium Channels;Ion Channels as Targets in Drug Discovery;2024